Spineway (ALSPW) - Cash Flow Conversion Efficiency

Latest as of June 2025: 0.023x

Based on the latest financial reports, Spineway (ALSPW) has a cash flow conversion efficiency ratio of 0.023x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€538.00K ≈ $628.98K USD) by net assets (€23.86 Million ≈ $27.90 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Spineway - Cash Flow Conversion Efficiency Trend (2011–2024)

This chart illustrates how Spineway's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read Spineway debt and liabilities for a breakdown of total debt and financial obligations.

Spineway Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Spineway ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Dom Maklerski IDM SA WAR:IDM	0.421x
HeartCore Enterprises Inc NASDAQ:HTCR	-0.031x
N1 Holdings Ltd AU:N1H	8.014x
Sanginita Chemicals Limited NSE:SANGINITA	0.014x
Spacetalk Ltd AU:SPA	-0.153x
Aquila SA PA:ALAQU	0.052x
Nandani Creation Limited NSE:JAIPURKURT	-0.168x
Da Lue International Holding Co Ltd TWO:4804	0.027x

Annual Cash Flow Conversion Efficiency for Spineway (2011–2024)

The table below shows the annual cash flow conversion efficiency of Spineway from 2011 to 2024. For the full company profile with market capitalisation and key ratios, see Spineway market cap and net worth.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	€24.24 Million ≈ $28.34 Million	€-3.27 Million ≈ $-3.83 Million	-0.135x	+55.85%
2023-12-31	€19.05 Million ≈ $22.28 Million	€-5.83 Million ≈ $-6.81 Million	-0.306x	-315.53%
2022-12-31	€22.01 Million ≈ $25.73 Million	€-1.62 Million ≈ $-1.89 Million	-0.074x	+14.38%
2021-12-31	€20.88 Million ≈ $24.41 Million	€-1.79 Million ≈ $-2.10 Million	-0.086x	-111.09%
2020-12-31	€10.02 Million ≈ $11.71 Million	€-408.00K ≈ $-476.99K	-0.041x	+77.22%
2019-12-31	€6.49 Million ≈ $7.59 Million	€-1.16 Million ≈ $-1.36 Million	-0.179x	+95.04%
2018-12-31	€945.00K ≈ $1.10 Million	€-3.41 Million ≈ $-3.99 Million	-3.608x	-593.91%
2017-12-31	€1.77 Million ≈ $2.07 Million	€-922.00K ≈ $-1.08 Million	-0.520x	-241.43%
2016-12-31	€1.30 Million ≈ $1.52 Million	€-198.00K ≈ $-231.48K	-0.152x	-364.80%
2015-12-31	€3.02 Million ≈ $3.53 Million	€-99.00K ≈ $-115.74K	-0.033x	+91.21%
2014-12-31	€4.62 Million ≈ $5.41 Million	€-1.72 Million ≈ $-2.01 Million	-0.373x	-68.98%
2013-12-31	€5.12 Million ≈ $5.99 Million	€-1.13 Million ≈ $-1.32 Million	-0.221x	-167.96%
2012-12-31	€1.16 Million ≈ $1.36 Million	€378.00K ≈ $441.92K	0.324x	+172.35%
2011-12-31	€844.99K ≈ $987.88K	€-379.00K ≈ $-443.09K	-0.449x	--

About Spineway

PA:ALSPW France Medical Instruments & Supplies

Market Cap

$6.22 Million

€5.32 Million EUR

Market Cap Rank

#27934 Global

#506 in France

Share Price

€0.15

Change (1 day)

-0.13%

52-Week Range

€0.12 - €0.23

All Time High

€1000000.00